Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: GlaxoSmithKline UK Limited 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom Trading as: GlaxoSmithKline UK Ltd Stockley Park West Uxbridge Middlesex UB11 1BT
Avodart 0.5 mg soft capsules.
| Pharmaceutical Form |
|---|
|
Capsules, soft. The capsules are opaque, yellow, oblong soft gelatin capsules imprinted with GX CE2 on one side in red ink. |
Each capsule contains 0.5 mg dutasteride.
For a full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT. |
| List of Excipients |
|---|
|
Capsule contents: Mono- and diglycerides of caprylic/capric acid Capsule shell: Gelatin |
Blisters of opaque PVC/PVDC film containing 10 soft gelatin capsules packed into containers of 10, 30, 60 and 90 capsules. Not all pack sizes may be marketed.
GlaxoSmithKline UK Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
Trading as:
GlaxoSmithKline UK Ltd
Stockley Park West
Uxbridge
Middlesex
UB11 1BT
19494/0006
17 January 2003 / 13 February 2008
| Drug | Countries | |
|---|---|---|
| AVODART | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.